1Calcutt NA, Jolivah CG, Fernyhough P. Growth factors as therapeutics for diabetic neuropathy [ J ]. Curr Drug Targets, 2008, 9 ( 1 ) : 47 - 59.
2Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy [ J ].J Neurosci Res, 1990, 26(2) : 258 -267.
3Karamoysoyli E, Bumand RC, Tomlinson DR, et al. Neuritin mediates nerve growth faetor-indueed axonal regeneration and is effieient in experimental diabetic neuropathy [ J ]. Diabetes, 2008, 57 ( 1 ) : 181 - 189.
4Hellweg R, Raivich G, Hariung HD, et al. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy [ J ]. Exp Neurol, 1994, 130( 1 ) : 24 -30.
5Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications [ J ]. Horm Res, 2000, 53 (2) : 53 - 67.
6Terenghi G. Peripheral nerve regeneration and neurotropic factors [ J ]. J Anat, 1999, 194 ( Pt 1): 1-14.
7Gold BG, Mobley WC, Matheson SF. Regulation of axonal caliber, neurofilament content, and nuclear localigation in mature sensory neurons by nerve growth factor [J]. J Neurosci, 1991, 11 (4) : 943 - 955.
8Lee PG, Hohman TC, Cai F, et al. Streptozotoein-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve [ J ]. Exp Neurol, 2001, 170(1) : 149 - 161.
